Abbott Laboratories
ABT

Abbott Laboratories (ABT) earnings history

Most recent quarter

Period end
Jun 30, 2026
Revenue
$12.6B
Reported
Jul 16, 2026

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2026Jul 16, 2026$1.31$1.31+0.00%$12.6BSEC
Q1 2026Apr 16, 2026$1.14$1.15+0.46%$11.2BSEC
Q4 2025Jan 22, 2026$1.50$1.50+0.27%$11.5BSEC
Q3 2025Oct 15, 2025$1.30$1.30−0.21%$11.4BSEC
Q2 2025Jul 17, 2025$1.26$1.26+0.33%$11.1BSEC
Q1 2025Apr 16, 2025$1.07$1.09+1.66%$10.4BSEC
Q4 2024Jan 22, 2025$1.34$1.34−0.19%$11.0BSEC
Q3 2024Oct 16, 2024$1.20$1.21+0.65%$10.6BSEC
Q2 2024Jul 18, 2024$1.11$1.14+3.17%$10.4BSEC
Q1 2024Apr 17, 2024$0.96$0.98+2.62%$10.0BSEC
Q4 2023Jan 24, 2024$1.19$1.19+0.03%$10.2BSEC
Q3 2023Oct 18, 2023$1.10$1.14+3.57%$10.1BSEC
Q2 2023Jul 20, 2023$1.05$1.08+2.89%$10.0BSEC
Q1 2023Apr 19, 2023$0.99$1.03+4.01%$9.7BSEC
Q4 2022Jan 25, 2023$0.93$1.03+11.27%$10.1BSEC
Q3 2022Oct 19, 2022$0.94$1.15+21.93%$10.4BSEC
Q2 2022Jul 20, 2022$1.13$1.43+26.86%$11.3B
Q1 2022Apr 20, 2022$1.47$1.73+18.09%$11.9B
Q4 2021Jan 26, 2022$1.21$1.32+9.41%$11.5B
Q3 2021Oct 20, 2021$0.94$1.40+48.16%$10.9B

Quarterly revenue

Q3 2021
$10.9B
Q4 2021
$11.5B
Q1 2022
$11.9B
Q2 2022
$11.3B
Q3 2022
$10.4B
Q4 2022
$10.1B
Q1 2023
$9.7B
Q2 2023
$10.0B
Q3 2023
$10.1B
Q4 2023
$10.2B
Q1 2024
$10.0B
Q2 2024
$10.4B
Q3 2024
$10.6B
Q4 2024
$11.0B
Q1 2025
$10.4B
Q2 2025
$11.1B
Q3 2025
$11.4B
Q4 2025
$11.5B
Q1 2026
$11.2B
Q2 2026
$12.6B

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.